SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-04-002516
Filing Date
2004-03-15
Accepted
2004-03-15 14:43:03
Documents
10
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 ATHEROGENICS INC. g87719e10vk.htm 10-K 563341
3 EX-10.25 2ND LOAN MODIFICATION AGREEMENT g87719exv10w25.txt EX-10.25 10227
4 EX-10.26 3RD LOAN MODIFICATION AGREEMENT g87719exv10w26.txt EX-10.26 23329
5 EX-10.27 NEGATIVE PLEDGE AGREEMENT DATED 12/29/03 g87719exv10w27.txt EX-10.27 6568
6 EX-23.01 CONSENT OF ERNST & YOUNG g87719exv23w01.txt EX-23.01 636
7 EX-24.01 POWERS OF ATTORNEY g87719exv24w01.txt EX-24.01 3352
8 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g87719exv31w1.txt EX-31.1 3404
9 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g87719exv31w2.txt EX-31.2 3466
10 EX-32 SECTION 906 CERTIFICATION OF THE CEO & CFO g87719exv32.txt EX-32 2851
11 GRAPHIC g87719g8771900.gif GRAPHIC 3098
  Complete submission text file 0000950144-04-002516.txt   622938
Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Filer) CIK: 0001107601 (see all company filings)

IRS No.: 582108232 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31261 | Film No.: 04669054
SIC: 2834 Pharmaceutical Preparations